Insulet Corporation: FDA filings under this applicant name
FDA lists 25 510(k) clearances under 2 spellings of the applicant name “Insulet Corporation” (first 2003, latest 2026), across 4 product codes in 1 review panel. Median 510(k) review time under this name: 119 days. Since 2017 the median was 132 days, against 99 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 73 |
| 2013 | 1 | 115 |
| 2014 | 1 | 265 |
| 2015 | 0 | — |
| 2016 | 1 | 86 |
| 2017 | 1 | 245 |
| 2018 | 1 | 144 |
| 2019 | 3 | 88 |
| 2020 | 0 | — |
| 2021 | 1 | 84 |
| 2022 | 5 | 400 |
| 2023 | 3 | 119 |
| 2024 | 2 | 166 |
| 2025 | 1 | 176 |
| 2026 | 1 | 56 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Insulet Corporation took a median 132 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 99 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LZG | Pump, Infusion, Insulin | 13 | 13 |
| QJI | Interoperable Automated Glycemic Controller | 6 | 6 |
| QFG | Alternate Controller Enabled Insulin Infusion Pump | 3 | 3 |
| QRX | Continuous Glucose Monitor Informed Insulin Dose Calculator | 3 | 3 |
Review panels
- Clinical Chemistry (25)
Most recent Insulet Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K261461 | Omnipod 6 algorithm | QJI | 2026-06-29 | 56 |
| K251779 | Omnipod 5 algorithm | QJI | 2025-12-03 | 176 |
| K241777 | SmartAdjust Technology | QJI | 2024-08-26 | 67 |
| K232741 | SmartAdjust(TM) technology | QJI | 2024-05-29 | 265 |
| K231826 | Omnipod 5 ACE Pump | QFG | 2023-10-18 | 119 |
| K231824 | SmartBolus Calculator | QRX | 2023-10-18 | 119 |
| K223372 | Omnipod GO Insulin Delivery Device | LZG | 2023-04-24 | 171 |
| K222239 | SmartBolus Calculator | QRX | 2022-08-19 | 24 |
| K220394 | SmartAdjust(TM) technology | QJI | 2022-08-19 | 189 |
| K203774 | SmartAdjust technology | QJI | 2022-01-27 | 400 |
15 earlier clearances. See the full list in Caduvo.
Recalls
21 product recalls in 15 recall events; 10 initiated in the last five years. Most recent: 2026-05-20.
2 product recalls in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Elcam Medical, Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Insulet Corporation is the lead sponsor of 23 device studies on ClinicalTrials.gov (6 active or recruiting). Most recent:
- NCT07593625: Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D (Recruiting, started 2026-05-25)
- NCT07579702: Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System (Recruiting, started 2026-05-13)
- NCT07521475: Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes (Recruiting, started 2026-04-30)
- NCT07317102: Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) (Recruiting, started 2026-03-16)
- NCT07276776: An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes (Completed, started 2025-12-12)
SEC filings
INSULET CORP (PODD): EDGAR filings, CIK 1145197. An SEC registrant with the same name, matched by name only.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Insulet Corporation (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via LZG)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via LZG)
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Insulet Corporation (24)
- Insulet Corp. (1)
Frequently asked questions
How many FDA 510(k) clearances are listed under Insulet Corporation?
FDA lists 25 510(k) clearances under 2 spellings of the applicant name “Insulet Corporation” (first 2003, latest 2026), across 4 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Insulet Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Insulet Corporation is 119 days. Since 2017: 132 days, versus 99 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Insulet Corporation?
The most frequent FDA product codes under this applicant name are LZG (Pump, Infusion, Insulin, 13); QJI (Interoperable Automated Glycemic Controller, 6); QFG (Alternate Controller Enabled Insulin Infusion Pump, 3).
Next steps
- See all 25 Insulet Corporation clearances with predicates and recalls
- Run predicate analysis for product code LZG, Insulet Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.